Nakano H - Search Results

1

DREAMM-11, Part 2: Japanese phase I trial of belantamab mafodotin combination therapies in relapsed/refractory multiple myeloma.

Sunami K, Iida S, Tsukada N, Fujii T, Kato H, Fukushima R, Wakabayashi S, Nakano H, Roy-Ghanta S, Kremer BE. Sunami K, et al. Among authors: nakano h. Int J Hematol. 2024 Dec 24. doi: 10.1007/s12185-024-03889-8. Online ahead of print. Int J Hematol. 2024. PMID: 39718747

2

[Diffuse large B-cell lymphoma concurrent with Kaposi's sarcoma in the same lymph node in a human immunodeficiency virus-negative patient].

Nakashima S, Ohara S, Imai Y, Nakano H, Uchida T, Inoue M, Hagihara M. Nakashima S, et al. Among authors: nakano h. Rinsho Ketsueki. 2024;65(2):74-77. doi: 10.11406/rinketsu.65.74. Rinsho Ketsueki. 2024. PMID: 38448001 Japanese.

3

Increased trough concentration of venetoclax when combined with itraconazole for acute myeloid leukemia.

Hagihara M, Yasu T, Gando Y, Sugi T, Nakashima S, Imai Y, Nakano H, Uchida T, Inoue M. Hagihara M, et al. Among authors: nakano h. Ann Hematol. 2024 Nov;103(11):4497-4502. doi: 10.1007/s00277-024-05845-2. Epub 2024 Sep 27. Ann Hematol. 2024. PMID: 39327313

4

[Analysis of anti-SARS-CoV-2 IgG antibody titers after mRNA booster vaccination in patients with nonmalignant hematological disorders].

Hagihara M, Sugi T, Hayashi H, Nakashima S, Ohara S, Imai Y, Nakano H, Uchida T, Inoue M, Mitamura K. Hagihara M, et al. Among authors: nakano h. Rinsho Ketsueki. 2023;64(2):133-136. doi: 10.11406/rinketsu.64.133. Rinsho Ketsueki. 2023. PMID: 36990734 Japanese.

5

[Outcomes of COVID-19 due to omicron variant infection complicated with hematological disorders].

Hagihara M, Hayashi H, Nakajima S, Imai Y, Nakano H, Uchida T, Inoue M, Miyawaki M, Ikeda N, Konuma R, Atsuta Y, Tanaka M, Imamura A. Hagihara M, et al. Among authors: nakano h. Rinsho Ketsueki. 2023;64(1):3-8. doi: 10.11406/rinketsu.64.3. Rinsho Ketsueki. 2023. PMID: 36775303 Japanese.

6

Pathological complete response after chemotherapy in initially unresectable distal cholangiocarcinoma.

Nakayama T, Nakano H, Matsushita R, Hayakawa T, Takagi S, Tanaka Y, Ozaki T, Matsushita T, Sumi Y, Takagi M. Nakayama T, et al. Among authors: nakano h. Clin J Gastroenterol. 2024 Dec 28. doi: 10.1007/s12328-024-02084-w. Online ahead of print. Clin J Gastroenterol. 2024. PMID: 39731697

7

Globular-shaped Aβ oligomers have diverse mechanisms for promoting Aβ aggregations with the facilitation of fibril elongation.

Nakano H, Hikishima S, Mori M, Minamikawa J, Muramatsu D, Sakashita Y, Ikeda T, Noguchi-Shinohara M, Teplow DB, Ono K. Nakano H, et al. Neurobiol Dis. 2024 Dec 22:106775. doi: 10.1016/j.nbd.2024.106775. Online ahead of print. Neurobiol Dis. 2024. PMID: 39719197 Free article.

8

A Pilot Study on Developed Shoes That Enhance Gait Parameters Without Increasing Muscle Activity.

Abiko T, Murata S, Kai Y, Nakano H, Sakamoto M, Suzuki K, Matsuo D, Kawaguchi M. Abiko T, et al. Among authors: nakano h. Appl Bionics Biomech. 2024 Dec 14;2024:5587738. doi: 10.1155/abb/5587738. eCollection 2024. Appl Bionics Biomech. 2024. PMID: 39712671 Free PMC article.

9

Activities of the Research Group for Comprehensive Research of Gene Mutation-related Rare and Intractable Diseases of the Skin within the Project for Research on Intractable Diseases of the Ministry of Health, Labor, and Welfare of Japan.

Hashimoto T, Moriwaki SI, Iwata H, Furumura M, Hayama K, Kanazawa N, Kambe N, Nomura T, Yoneda K, Kawakami T, Nakano H, Akasaka E, Tateishi C, Ota K, Shintani A, Tsuruta D. Hashimoto T, et al. Among authors: nakano h. Keio J Med. 2024 Dec 21. doi: 10.2302/kjm.2024-0016-IR. Online ahead of print. Keio J Med. 2024. PMID: 39710404 Free article.

10

Improving adherence by investigating the stability of dabigatran outside of the manufacturer's original packaging: a New Zealand perspective.

Noori Z, Griffiths D, Jung S, Huang C, Nakano H, Wong M, Jaiswal JK, Sharma M. Noori Z, et al. Among authors: nakano h. Expert Opin Drug Deliv. 2024 Dec 24:1-10. doi: 10.1080/17425247.2024.2444359. Online ahead of print. Expert Opin Drug Deliv. 2024. PMID: 39690917

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,766 results

Search Page

Filters